Enzyme prodrug therapies and therapeutic enzymes.
暂无分享，去创建一个
[1] E. Wang,et al. Designing metal‐contained enzyme mimics for prodrug activation , 2017, Advanced drug delivery reviews.
[2] Jarkko Rautio,et al. Prodrugs in medicinal chemistry and enzyme prodrug therapies , 2017, Advanced drug delivery reviews.
[3] Sur Sharma,et al. Antibody Directed Enzyme Prodrug Therapy (ADEPT): Trials and tribulations , 2017, Advanced drug delivery reviews.
[4] A. Annala,et al. Cell‐mediated enzyme prodrug cancer therapies , 2017, Advanced drug delivery reviews.
[5] S. Muro,et al. Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives , 2017, Advanced drug delivery reviews.
[6] G. Tiram,et al. Two-step polymer- and liposome-enzyme prodrug therapies for cancer: PDEPT and PELT concepts and future perspectives. , 2017, Advanced drug delivery reviews.
[7] M. Tangney,et al. Designer bacteria as intratumoural enzyme biofactories , 2017, Advanced drug delivery reviews.
[8] Fabian Itel,et al. Enzymes as key features in therapeutic cell mimicry , 2017, Advanced drug delivery reviews.
[9] A. Zelikin,et al. Substrate Mediated Enzyme Prodrug Therapy , 2012, PloS one.
[10] T. Sakai,et al. Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules. , 1985, Cancer research.
[11] T. Katsuragi,et al. Implantable encapsulated cytosine deaminase having 5-fluorocytosine-deaminating activity , 1985 .